Thymosin added to colorectal cancer therapy shows immune signals but evidence falls short
A systematic review of 30 controlled studies finds thymosin raises certain immune markers and performance status in colorectal cancer, but certainty is low or very low and routine…
TR
By Tom Reyes · Markets Editor
Oct 29 04:48 ETSource: Bioengineer.org
From the source
Read at bioengineer.orgThymosin added to colorectal cancer therapy shows immune signals but evidence falls short
A systematic review of 30 controlled studies finds thymosin raises certain immune markers and performance status in colorectal cancer, but certainty is low or very low and routine use is not supported.
